Clin2
NCT06741904Possibly a fitEnrolling by invitation

Predicting liver disease worsening without invasive tests

Chronic Liver Disease and Cirrhosis

Part of Digestive system clinical trials.

This study looks at new, non-invasive methods to predict when chronic liver disease might get worse. It could help you and your doctor catch problems early without needing a biopsy or other invasive procedures.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,334 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You are between 18 and 80 years old.
  • You have chronic liver disease (any cause).
  • Your liver stiffness measurement is above 10 kPa, or you have been diagnosed with cirrhosis by imaging or biopsy.
  • You have not had a liver transplant or a TIPS procedure.
  • You have no past or current liver cancer or other cancers.
  • You do not have a blood clot in the portal vein.
  • You still have your spleen (no splenectomy or splenic embolization).
  • You are not currently in a decompensated stage (no variceal bleeding, moderate to severe ascites, or hepatic encephalopathy).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07042308Recruiting
Study of advanced chronic liver disease over time

This study follows people with advanced chronic liver disease to understand how their condition changes over time. If you have cirrhosis or high liver stiffness, you may be able to join to help researchers track the disease and learn more about it.

Hong Kong
NCT07820644Recruiting
Liver cancer risk prediction in chronic liver disease

This study aims to predict the risk of developing liver cancer in people with chronic liver conditions such as hepatitis B or C, cirrhosis, or fatty liver disease. By participating, you may help researchers improve early detection and prevention strategies for liver cancer.

Shenzhen, Guangdong
NCT07036874Recruiting
Predicting outcomes in liver cancer with non-invasive tests

This study uses non-invasive tests, like scans or blood tests, to predict how well people with liver cancer (hepatocellular carcinoma, or HCC) will do after curative treatment. It may help doctors better understand your condition without needing invasive procedures.

Hong Kong
NCT05312853Not yet recruiting
Non-invasive tests to track chronic liver disease

This study is looking for a better way to diagnose and track chronic liver disease without invasive procedures like biopsies. If you join, researchers will use simple tests (like blood tests or imaging) to see how well they predict the progression of your liver condition.

Mainz
NCT07031843Recruiting
New prediction model study for liver cirrhosis

This study is exploring a new way to predict how liver cirrhosis will progress. It may help doctors better understand and manage the condition.

Chongqing, Chongqing Municipality
NCT07087041Not yet recruiting
Predicting liver recovery with spleen stiffness and blood tests

This study looks at whether measuring spleen stiffness and simple blood tests can predict if the liver will recover in people with decompensated cirrhosis. It may help doctors know which patients can improve with treatment.

Beijing, Beijing Municipality

Hear when a new Chronic Liver Disease and Cirrhosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.